Molecular markers of paragangliomas/pheochromocytomas - Test2 - elhamkhani - TriplyDB

Molecular markers of paragangliomas/pheochromocytomas

Molecular markers of paragangliomas/pheochromocytomas

http://www.wikidata.org/entity/Q33649025

about

Preoperative risk factors for massive blood loss in adrenalectomy for pheochromocytoma.Exome analysis of carotid body tumor.Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma

P2860

Q47166628-A48B311B-7F7B-4C90-9AE4-01805491FD81 Q52674249-F9E49630-D1EC-4DBB-942C-BC965CB0E576 Q58553604-9A223FCF-0C52-4106-874A-286D5444A5C7

P2860

Molecular markers of paragangliomas/pheochromocytomas

http://www.wikidata.org/entity/Q33649025

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Molecular markers of paragangliomas/pheochromocytomas

@ast

Molecular markers of paragangliomas/pheochromocytomas

@en

type

label

Molecular markers of paragangliomas/pheochromocytomas

@ast

Molecular markers of paragangliomas/pheochromocytomas

@en

prefLabel

Molecular markers of paragangliomas/pheochromocytomas

@ast

Molecular markers of paragangliomas/pheochromocytomas

@en

P1433

Q33649025-0D6A3CC8-2F53-4004-91E3-598E2E9DE178

P1476

Q33649025-3ABD5525-7A64-426A-96BF-4A7095AB8F7C

P2093

Q33649025-08C583F9-FAF2-4EC0-9781-8209217C3616

Q33649025-11D8E866-A678-48ED-BE06-525AC9519C13

Q33649025-3E1637F7-2CB4-4621-8AB1-9877E6FC50C9

Q33649025-54A1819D-5EBB-4A8A-B48E-7AB2D730D332

Q33649025-660ECDBB-311D-4774-B0EE-364D6DBB5A01

Q33649025-7C6BA098-0020-4C6A-84D3-6FFB935E0A87

Q33649025-87FD56D7-7C11-4FFE-B6C9-1E453907F7C2

Q33649025-886335AE-7CF9-44D8-B92A-C89136DD6645

Q33649025-B5E34895-4FC8-4C95-BDE2-04E706A25EC9

P275

Q33649025-9EF40A30-C4DF-4494-966F-95315F11B256

P2860

Q33649025-0005F9DC-8542-4EF8-9B18-29FC1D0A8E8E

Q33649025-0091C5AC-6834-4570-909C-9AAFF066247B

Q33649025-0120DB0B-7446-453F-9A27-A515D2A2C488

Q33649025-02587F10-0AF4-4054-B3B2-939208E48182

Q33649025-0485E52C-6A78-4395-B951-569265332090

Q33649025-04E06DC7-D70E-44C3-88FE-3BD5270E470E

Q33649025-0654DD96-E0D5-4C4A-8CE0-4D60BA11C69C

Q33649025-06626D25-313B-4A97-81E9-F211635834A2

Q33649025-068F52C7-AA3E-4ECF-BFDA-8D7083B4FBB6

Q33649025-06952F60-9D2C-4FB4-8CA4-DA267864AAC6

P304

Q33649025-D39B5B8D-EEC2-40A2-A5F2-60DFC298524A

P31

Q33649025-23A2C3AE-9977-4AAB-A326-26823C027FD7

P356

Q33649025-11B78341-4BD7-477C-9CAF-38E0D81599E1

P407

Q33649025-C6BBE5FA-CAD1-4C0F-9ADA-064BBB48D02B

P433

Q33649025-84A677DF-B29B-4548-A987-8AF9E1CA6A56

P478

Q33649025-0BD29581-3AB4-48AF-99B8-D882174BDDC3

P50

Q33649025-041D24EC-67DD-4A37-8E15-480B6313C995

Q33649025-40EB697A-F6CD-4750-94E6-2B1CFE63E6FC

Q33649025-69ED3F66-1D39-4A02-809B-F1540124F6C8

Q33649025-AB830E77-C7A8-4ED5-962E-CFADB94BEC0B

P5008

Q33649025-248B763D-08EC-4C35-8D12-A7AC9DF391AB

P577

Q33649025-63C6EE9F-B4DB-4F52-8DE9-58C8A7B61954

P698

Q33649025-6AF816A0-EFD2-4B72-A39C-C1DC68BA35C2

P921

Q33649025-3286F4CB-3469-4810-8E77-A4999FA4E3BF

Q33649025-56C72E40-660F-4AB6-B94A-5603A9C440DC

Q33649025-5C6FCB51-19EE-4E34-8F9C-D63E57032D9F

Q33649025-C1C67C21-F646-4A15-ABE9-B88A06BA6941

P932

Q33649025-5D59C65E-A8BF-4089-8F47-0E29E0F22C59

P356

ONCOTARGET.15201

P1433

P1476

Molecular markers of paragangliomas/pheochromocytomas

@en

P2093

Alexander L Golovyuk

http://www.w3.org/2001/XMLSchema#string

Anastasiya V Snezhkina

http://www.w3.org/2001/XMLSchema#string

Anatoly V Pokrovsky

http://www.w3.org/2001/XMLSchema#string

Andrew R Zaretsky

http://www.w3.org/2001/XMLSchema#string

Anna V Kudryavtseva

http://www.w3.org/2001/XMLSchema#string

Boris Y Alekseev

http://www.w3.org/2001/XMLSchema#string

George S Krasnov

http://www.w3.org/2001/XMLSchema#string

Oleg A Stepanov

http://www.w3.org/2001/XMLSchema#string

Svetlana O Zhikrivetskaya

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription

Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function

P304

25756-25782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.15201

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alexei Dmitriev

Nataliya Melnikova

Dmitry V Kalinin

P5008

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28187001

http://www.w3.org/2001/XMLSchema#string

P921

adrenal gland neoplasm

phaeochromocytoma

tumor biomarkers

P932

5421967

http://www.w3.org/2001/XMLSchema#string